344 related articles for article (PubMed ID: 32929860)
1. Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice.
Werner G; Damme M; Schludi M; Gnörich J; Wind K; Fellerer K; Wefers B; Wurst W; Edbauer D; Brendel M; Haass C; Capell A
EMBO Rep; 2020 Oct; 21(10):e50241. PubMed ID: 32929860
[TBL] [Abstract][Full Text] [Related]
2. Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice.
Zhou X; Brooks M; Jiang P; Koga S; Zuberi AR; Baker MC; Parsons TM; Castanedes-Casey M; Phillips V; Librero AL; Kurti A; Fryer JD; Bu G; Lutz C; Dickson DW; Rademakers R
EMBO Rep; 2020 Oct; 21(10):e50197. PubMed ID: 32761777
[TBL] [Abstract][Full Text] [Related]
3. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED
Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528
[TBL] [Abstract][Full Text] [Related]
4. Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency.
Zhou X; Sun L; Brady OA; Murphy KA; Hu F
Acta Neuropathol Commun; 2017 Jan; 5(1):9. PubMed ID: 28126008
[TBL] [Abstract][Full Text] [Related]
5. Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice.
Feng T; Mai S; Roscoe JM; Sheng RR; Ullah M; Zhang J; Katz II; Yu H; Xiong W; Hu F
EMBO Rep; 2020 Oct; 21(10):e50219. PubMed ID: 32852886
[TBL] [Abstract][Full Text] [Related]
6. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice.
Götzl JK; Colombo AV; Fellerer K; Reifschneider A; Werner G; Tahirovic S; Haass C; Capell A
Mol Neurodegener; 2018 Sep; 13(1):48. PubMed ID: 30180904
[TBL] [Abstract][Full Text] [Related]
7. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A
Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111
[TBL] [Abstract][Full Text] [Related]
8. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
[TBL] [Abstract][Full Text] [Related]
9. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
[TBL] [Abstract][Full Text] [Related]
10. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM
J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706
[TBL] [Abstract][Full Text] [Related]
11. Lack of a protective effect of the Tmem106b "protective SNP" in the Grn knockout mouse model for frontotemporal lobar degeneration.
Cabron AS; Borgmeyer U; Richter J; Peisker H; Gutbrod K; Dörmann P; Capell A; Damme M
Acta Neuropathol Commun; 2023 Jan; 11(1):21. PubMed ID: 36707901
[TBL] [Abstract][Full Text] [Related]
12. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R
Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100
[TBL] [Abstract][Full Text] [Related]
13. Progranulin and TMEM106B: when two become wan.
Clayton EL; Isaacs AM
EMBO Rep; 2020 Oct; 21(10):e51668. PubMed ID: 32985120
[TBL] [Abstract][Full Text] [Related]
14. Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration.
Reich M; Simon MJ; Polke B; Paris I; Werner G; Schrader C; Spieth L; Davis SS; Robinson S; de Melo GL; Schlaphoff L; Buschmann K; Berghoff S; Logan T; Nuscher B; de Weerd L; Edbauer D; Simons M; Suh JH; Sandmann T; Kariolis MS; DeVos SL; Lewcock JW; Paquet D; Capell A; Di Paolo G; Haass C
Sci Transl Med; 2024 Jun; 16(750):eadj7308. PubMed ID: 38838131
[TBL] [Abstract][Full Text] [Related]
15. Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.
Klein ZA; Takahashi H; Ma M; Stagi M; Zhou M; Lam TT; Strittmatter SM
Neuron; 2017 Jul; 95(2):281-296.e6. PubMed ID: 28728022
[TBL] [Abstract][Full Text] [Related]
16. Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations.
Huang M; Modeste E; Dammer E; Merino P; Taylor G; Duong DM; Deng Q; Holler CJ; Gearing M; Dickson D; Seyfried NT; Kukar T
Acta Neuropathol Commun; 2020 Oct; 8(1):163. PubMed ID: 33028409
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.
Zhou X; Kukar T; Rademakers R
Adv Exp Med Biol; 2021; 1281():219-242. PubMed ID: 33433878
[TBL] [Abstract][Full Text] [Related]
18. Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations.
Davis SE; Cook AK; Hall JA; Voskobiynyk Y; Carullo NV; Boyle NR; Hakim AR; Anderson KM; Hobdy KP; Pugh DA; Murchison CF; McMeekin LJ; Simmons M; Margolies KA; Cowell RM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Arrant AE
Acta Neuropathol Commun; 2023 Apr; 11(1):70. PubMed ID: 37118844
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging.
Perneel J; Neumann M; Heeman B; Cheung S; Van den Broeck M; Wynants S; Baker M; Vicente CT; Faura J; Rademakers R; Mackenzie IRA
Acta Neuropathol; 2023 Mar; 145(3):285-302. PubMed ID: 36527486
[TBL] [Abstract][Full Text] [Related]
20. Intracellular Proteolysis of Progranulin Generates Stable, Lysosomal Granulins that Are Haploinsufficient in Patients with Frontotemporal Dementia Caused by
Holler CJ; Taylor G; Deng Q; Kukar T
eNeuro; 2017; 4(4):. PubMed ID: 28828399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
